We always promise
the best care

GS(Breast Center) Prof. Cho, Young eop

Schedule Mon Tues Wed Thurs Fri Sat
AM
PM

Specialty

Breast cancer, Benign breast diseases

Professor Career

  • Inha University
  • Yonsei University

Medical Experience

  • Head, Women's cancer center, Inha University Hostpial
  • Director, Surgery, Inha University Hospital
  • Director, Breast Surgery , Severance hospital, Yonsei University
  • Head, Breast cancer center, Yonser Cancer Center, Severance hospital, Yonsei University
  • Breast center, CHA Ilsan medical center, CHA University

Society, Research, Training, Awards

  • Visiting Scholar, Norris cancer center, University of Southern California, USA
  • Vice-president, Korean Society of Lymphedema
  • Vice-president, Korean Breast Cancer Society
  • Executive Director, Korean Surgical Society
  • Inspector, Korean Society of Surgical Oncology
  • Official commendation, The ministry of health and welfare

  • Paper
  1. Youngup Cho was born in Chungcheongbuk-Do, South Korea. He earned his M.D. from Yonsei University College of Medicine in 1985, Seoul, Korea. He completed an internship and a residency at Severance Hospital, Yonsei University Health System in Seoul and a clinical fellowship at the Kangnam Severance Hospital, Yonsei University Health System in 1994 after completing military service as Naval Major for three years.

    From 1995 to 2016, Cho served on the faculty of Inha University Medical College, where he was Chief Professor of Surgery and Clinical Director of the Women’s Cancer Center at Inha University Hospital for Breast & Endocrine Oncology. In 2016, he joined Yonsei Cancer Center as Clinical Professor and Director of Breast Cancer Center, as well as Chief of the Division of Breast Surgery in Severance Hospital's Department of Surgery. He has supervised training for foreign fellows from Saudi Arabia, Vietnam, Kazakhstan, Uzbekistan, Philippines, Mongolia and others.

    Cho is a leading member of the Korean Surgical Society, Korean Breast Cancer Society, Korean Society of Surgical Oncology and Korean Society of Lymphedema . Also he is a member of ESSO. He had served vice-editor for The Journal of Breast Cancer.

    He contributed to the books "Oekwahak(Korean text book of Surgery)", “Yoobanghak(Breast)” and “Jongyangoekwahak(Surgical Oncology). Cho has been the principal investigator on multiple clinical trials of surgical oncology and systemic therapy of breast cancer and an investigator for CREATE-X trial.

    Now he has moved to Cha University, Ilsan Medical Center. At Ilsan Cha Hospital, he has continued his work for the management for patients of breast cancer and benign diseases in Breast Center.
  2. Assessment of the Prognostic Staging System of American Joint Committee on Cancer 8th Edition for Breast Cancer: Comparisons with the Conventional Anatomic Staging System. J Breast Cancer. 2020 Jan 9;23(1):59-68. doi: 10.4048/jbc.2020.23.e9. eCollection 2020 Feb. PubMed PMID: 32140270; PubMed Central PMCID: PMC7043951.
  3. Coping style at diagnosis and its association with subsequent health-related quality of life in women with breast cancer: A 3-year follow-up study. Eur J Oncol Nurs. 2020 Apr;45:101726. doi: 10.1016/j.ejon.2020.101726. Epub 2020 Feb 7. PubMed PMID: 32155584.
  4. Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors. BMC Cancer. 2020 May 1;20(1):367. doi: 10.1186/s12885-020-06861-x. PubMed PMID:32357926.
  5. Pre-post analysis of a social capital-based exercise adherence intervention for breast cancer survivors with moderate fatigue: a randomized controlled trial. Support Care Cancer. 2020 Feb 26.
  6. Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older. Breast Cancer Res Treat. 2020 Feb;179(3):687-697
  7. Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast. Asian J Surg. 2019 Oct 26
  8. Robot-assisted Nipple-sparing Mastectomy with Immediate Breast Reconstruction: An Initial Experience. Sci Rep. 2019 Oct 30;9(1):15669.
  9. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast. Yonsei Med J. 2019 Nov;60(11):1028-1035
  10. Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30. Breast Cancer Res. 2019 Oct 16;21(1):110
  11. Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients? Ann Surg Treat Res. 2019 Aug;97(2):49-57
  12. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective. Ann Surg. 2019 Jul 23
  13. Development of an exercise adherence program for breast cancer survivors with cancer-related fatigue-an intervention mapping approach. Support Care Cancer. 2019 Dec;27(12):4745-4752.
  14. Changes in Bone Mineral Density in Women With Breast Cancer: A Prospective Cohort Study. Cancer Nurs. 2019 Mar/Apr;42(2):164-172.
  15. Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort. Breast Cancer Res Treat. 2019 May;175(1):203-215.
  16. Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI. Breast Cancer Res Treat. 2019 Apr;174(2):515-524.
  17. BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts. Sci Rep. 2018 Oct 15;8(1):15263. 31859-8.
  18. Gasless Robot-Assisted Nipple-Sparing Mastectomy: A Case Report. J Breast Cancer. 2018 Sep;21(3):334-338.
  19. A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide. Cancer Res Treat. 2019 Apr;51(2):812-818.
  20. External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence. Radiat Oncol J. 2018 Jun;36(2):139-146.
  21. Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment. J Breast Cancer. 2018 Jun;21(2):182-189.
  22. Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. J Breast Cancer. 2018 Jun;21(2):134-141.
  23. Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm. World J Surg. 2018 Dec;42(12):3969-3978
  24. A hierarchical prognostic model for risk stratification in patients with early breast cancer according to (18) F-fludeoxyglucose uptake and clinicopathological parameters. Cancer Med. 2018 Apr;7(4):1127-1134.
  25. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Res Treat. 2018 Jul;50(3):801-812.
  26. Conserving the Lymphatic Drainage of the Arm Using Axillary Reverse Mapping Procedure in Breast Cancer Patients. Clinical Lymphology and Lymphedema. 2017 May ;2(1):6-9